Authors
Loading...
Review explores TGF-β1's transition from tumour suppressor to promoter in cancer, indicating complex therapeutic implications.
Chao Huang (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: